VEGFA and colorectal carcinoma: Additionally, studies of bevacizumab, a monoclonal antibody targeting VEGF for patients with metastatic CRC, and inhibitors targeting the VEGF/VEGFR axis in CRC CT26-bearing mice, suggested that VEGF could promote the proliferation of Tregs.